NRx Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NRXP | TNXP | NMRA | VNDA | AVXL | MPLT | |
|---|---|---|---|---|---|---|
| Market cap | 123.39M | 113.88M | 82.17M | 274.50M | 139.97M | 477.95M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -8.1 | -0.8 | -0.7 | 22.7 | -2.7 | -2.5 |
| Price/book | -712.5 | 0.5 | 1.8 | 1.2 | 1.2 | 1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −8.65% | −63.61% | −74.41% | −12.62% | −82.83% | −51.85% |
| Today | 0.00% | −9.04% | −8.07% | −0.66% | +1.34% | −2.60% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All NRXP news ›HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
Jan 28, 2025, 08:05 ET "We are honored to partner with NRx and HOPE to tackle the pressing mental health challenges facing our nation, particularly within the military and veteran communities," said Dallas Sauer, Co-Founder of Smith &…
Head-To-Head Contrast: CASI Pharmaceuticals (NASDAQ:CASI) versus NRx Pharmaceuticals (NASDAQ:NRXP)
Posted by Danessa Lincoln on Oct 2nd, 2026 NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) and CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will…
$11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression Greatly Expands Application Potential for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
$11 Million Dollar Award for Robotic Magnetic Stimulation with openpr.com $11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression Greatly Expands Application Potential for NRx…
$11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
CorporateAds PRLog $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc - FDA-approved SPARC-TMS trial can now begin enrolling patients - Study…
NRx Pharmaceuticals (NASDAQ:NRXP) and Jaguar Animal Health (NASDAQ:JAGX) Head to Head Comparison
Posted by Tristan Rich on Sep 30th, 2026 NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) and Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
NewGen Announces Closing of $1.25 Million Public Offering
The Manila Times NewGen Announces Closing of $1.25 Million Public Offering BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the "Company”), a tech-forward, diversified, multi-jurisdictional high-growth…
NewGenIvf announces pricing of $1.25M public offering of shares (NIVF:NASDAQ)
NewGenIvf Group (NIVF) announced the pricing of public offering expected to generate approximately $1.25M in gross proceeds before placement agent fees and offering expenses.
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
prnewswire.com2
-
themarketsdaily.com2
-
freedom959.net1
-
kake.com1
-
ktvo.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.